2017年,度普利尤单抗(Dupilumab)获批成为一种治疗中重度特应性皮炎(AD)的有效药物,在适应证以外的慢性皮肤病治疗中也显示出了疗效.在病例报告和病例系列中,已报道Dupilumab在治疗慢性瘙痒症、结节性痒疹(PN)、湿疹、荨麻疹、大疱性类天疱疮(BP)方面的有效应用.临床试验正在评估Dupilumab对接触性皮炎(CD)、慢性手部湿疹(CHE)、斑秃(AA)、慢性自发性荨麻疹(CSU)和胆碱能性荨麻疹的疗效.

To report a case of tinea faciei caused by Trichophyton mentagrophytes which had been misdiagnosed for a long time.A 37-year-old female presented recurrent erythema,papule and blister on her face,accompanying with itching.She was misdiagnosed as Herpes simplex,Impetigo,Eczema,Skin infection,Seborrheic dermatitis and Acne rosacea,and successively treated with anti-viral,anti-bacterial and antianaphylaxis drugs.The lesion didn't resolve,but gradually expanded.After fungal examination,she was diagnosed as tinea faciei caused by Trichophyton mentagrophytes.The patient was cured by oral terbinafine combined with bifonazole cream.